Carol Ann,

It is my understanding that the progress on the supplement must be
described in the scientific narrative.

Zoya

--
Zoya Hamilton, CRA
Sr. Associate Director, Research Administration
Office of the Vice Provost
Tufts University
Tel (617) 636-6709
Fax (617) 636-2917
http://researchadmin.tufts.edu/

Amella, Carol Ann wrote:
>
> Hi everyone,
>
> We are getting ready to submit eSNAPS/2590-s for our parent awards who
> also have ARRA administrative supplement awards. We know that grantees
> need to include specific information on the ARRA additional funding as
> part of the annual progress report for the parent grant.
>
> *For the eSNAP, we are planning to select the type of supplement
> support from the ‘Supplement Support drop-down box’ in the _All
> Personnel Section_ of the report as directed in the /eSNAP April 12,
> 2010 guidelines page 23/.
>
> *For the 2590, we will indicate the analogous by using the
> abbreviations indicated in the /PHS2590 06/2009 guidelines page 24./
>
> Is anyone else mentioning the ARRA funds/ARRA progress in the
> scientific narrative or anywhere else in these eSNAP/2590 reports?
>
> Thank you,
>
> *Carol Ann *
>
> Carol Ann Amella
> Assistant Director
> Office of Grants and Contracts
> Feinstein Institute for Medical Research
> 350 Community Drive
> Manhasset, NY 11030
> ph-516-562-3106
> xxxxxx@nshs.edu <mailto:xxxxxx@nshs.edu>
>
> ---------------------------------------------------------------------------------
>
> The information contained in this electronic e-mail transmission
>
> and any attachments are intended only for the use of the individual
>
> or entity to whom or to which it is addressed, and may contain
>
> information that is privileged, confidential and exempt from
>
> disclosure under applicable law. If the reader of this communication
>
> is not the intended recipient, or the employee or agent responsible
>
> for delivering this communication to the intended recipient, you
>
> are hereby notified that any dissemination, distribution, copying
>
> or disclosure of this communication and any attachment is strictly
>
> prohibited. If you have received this transmission in error, please
>
> notify the sender immediately by telephone and electronic mail,
>
> and delete the original communication and any attachment from any
>
> computer, server or other electronic recording or storage device
>
> or medium. Receipt by anyone other than the intended recipient is
>
> not a waiver of any attorney-client, physician-patient or other
>
> privilege. Thank you.
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================